Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

NCT00197171 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

NCT03183492 ·Status: WITHDRAWN ·Phase: PHASE4

Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection

NCT05330455 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years

NCT02166671 ·Status: TERMINATED ·Phase: NA

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

NCT03866187 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

NCT00197119 ·Status: COMPLETED ·Phase: PHASE3

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

NCT03919578 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

NCT02153320 ·Status: COMPLETED ·Phase: PHASE1

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B

NCT02901951 ·Status: COMPLETED ·Phase: PHASE4

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

NCT00329576 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

NCT01345240 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

NCT00657657 ·Status: COMPLETED ·Phase: PHASE4

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

NCT01777295 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

NCT00289718 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older

NCT02735915 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine

NCT02692170 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

NCT05371080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

NCT00289770 ·Status: COMPLETED ·Phase: PHASE3

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

NCT00343915 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B

NCT00988767 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype

NCT00697749 ·Status: COMPLETED ·Phase: PHASE3

Hepatitis B Vaccine Delivered Trans-dermally by MAP

NCT06800131 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

NCT00508833 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A

NCT00139139 ·Status: COMPLETED ·Phase: NA

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

NCT02058589 ·Status: COMPLETED ·Phase: PHASE3